Physician
Psychiatry
Dr. Nicola G. Cascella, MD
|
|
Give Review
Nicola Cascella is an expert in the field of Psychiatry. Nicola G. Cascella is a published doctor. He published 51 publications, including: 'Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.' He is registered with Medicare.
Publications
- Risk of schizophrenia spectrum and affective Disorders associated with small for gestational age birth and height in adulthood.
- Gluten sensitivity and relationship to psychiatric symptoms in people with Schizophrenia.
- Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: Utility and limitation of the surrogate tissues in research for brain disord...
- Reduced anterior cingulate gray matter volume and thickness in subjects with Deficit schizophrenia.
- Increased prevalence of transglutaminase 6 antibodies in sera from Schizophrenia patients.
- Relationships between serum leptin level and severity of positive symptoms in Schizophrenia.
- Confirmatory factor analysis reveals a latent cognitive structure common to bipolar Disorder, schizophrenia, and normal controls.
- Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in Schizophrenia: Results from a randomized double blind placebo controlled...
- A gluten-free diet in people with Schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies.
- Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity.
- The insula-claustrum region and delusions in Schizophrenia.
- Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.
- A morphometric analysis of neuroanatomic abnormalities in traumatic brain injury.
- Peripheral olfactory system for clinical and basic psychiatry: a promising entry point to the mystery of brain mechanism and biomarker identification in Schizophrenia.
- Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric Illnesses.
- Neuropsychological functioning in bipolar Disorder and schizophrenia.
- Apathy syndrome after traumatic brain injury compared with Deficits in schizophrenia.
- Neuropsychological impairment in Deficit vs. non-Deficit schizophrenia.
- NeurodevelopMental involvement in schizophrenia: the olfactory epithelium as an alternative model for research.
- Schizophrenia and epilepsy: is there a shared susceptibility?
- Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in Schizophrenia.
- Negative symptoms of Schizophrenia correlate with impairment on the University of Pennsylvania smell identification test.
- Gray-matter abnormalities in Deficit schizophrenia.
- Positron emission tomography experience with 2-[(18) F]fluoro-3-(2(s)-azetidinylmethoxy)pyridine (2-[(18) F]fa) in the living human brain of smokers with paranoid schi...
- Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with Schizophrenia.
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and Schizophrenia by the novel PET radioligand [11C]OMAR.
- A large scale (N=400) investigation of gray matter differences in Schizophrenia using optimized voxel-based morphometry.
- ECT for catatonia in an autistic girl.
- DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex.
- The gluten connection: the association between Schizophrenia and celiac disease.
- Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
- Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions.
- PET-FDG test-retest reliability during a visual discrimination task in Schizophrenia.
- Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design.
- Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size.
- d-cycloserine adjuvant therapy to conventional neuroleptic treatment in Schizophrenia: an open-label study.
- Homicide in Capgras'' syndrome.
- Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
- Impulsiveness and subjective effects of intravenous cocaine administration in the laboratory.
- Cardiovascular responses to cocaine placebo in humans: a preliminary report.
- Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions.
- Cocaine-induced cocaine craving.
- Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose.
- Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose.
- Program for PET image alignment: effects on calculated differences in cerebral metabolic rates for glucose.
- Mapping the metabolic correlates of drug-induced euphoria.
- Effects of substance abuse on ventricular and sulcal measures assessed by computerised tomography.
- Pharmacologic properties of (-)-3PPP (preclamol) in man.
- Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly.
- Neuronal biomarkers from patients with Mental illnesses: a novel method through nasal biopsy combined with laser-captured microdissection.
Schools
University of Pisa Faculty of Medicine And Surgery
University MD
Johns Hopkins University School Med
Procedures Preformed
- Family Psychotherapy
- Psychiatric Evaluation
- Psychotherapy for Crisis
Conditions Treated
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Delusional Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Johns Hopkins University -
University of Maryland -
University of Pisa Faculty of Medicine
Hospital
-
University of Maryland St. Joseph Medical Center -
Sheppard Pratt Health System
Drug Facts
| NPI NUMBER | 1427007681 | |
| NPPES Provider LastName | CASCELLA | |
| NPPES Provider FirstName | NICOLA | |
| NPPES Provider ZIPCode | 212046819 | |
| NPPES Provider State | MD | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 678.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427007681 |
| Last Name Of The Provider | CASCELLA |
| First Name Of The Provider | NICOLA |
| View All |
Similar Doctors
|
|
Dr. Scott T. Aaronson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merle C. McCann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdul H. Ghori, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Magda A. Riega Echevarria, MD |
|
|
Dr. Sara L. Breitman-O'Conor, MD |
|
|
Dr. Briana M. Riemer, MD
This Doctor is OpenDoctor Recommended.
|